New Research Reveals How Psychedelics Rewire the Brain — By Turning Off the Outside World

For decades, the question of how psychedelics actually change the brain has remained one of the great open puzzles in neuroscience. We know they work — the clinical evidence for depression, PTSD, addiction, and trauma continues to mount — but the mechanism behind the experience itself has been surprisingly difficult to pin down. A study published this week in Communications Biology by researchers at Ruhr-University Bochum in Germany may have just changed that.

The team, led by Professor Dirk Jancke, used advanced real-time optical brain imaging to observe what happens in the brain when psychedelic compounds bind to serotonin 2A receptors — and what they found is both elegant and profound. What the Researchers Discovered When a psychedelic substance activates the 5-HT2A receptor, it suppresses the brain's ability to process incoming visual information. The regions responsible for interpreting what your eyes are actually seeing become quieter. But the brain does not simply go dark.

Instead, it compensates by pulling stored images and experiences from memory networks. "Visual information about things happening in the outside world becomes less accessible to our consciousness," explained Callum White, the study's first author. "To fill this gap in the puzzle, our brain inserts fragments from memory — it hallucinates.

We know they work — the clinical evidence for depression, PTSD, addiction, and trauma continues to mount — but the mechanism behind the experience itself has been surprisingly difficult to pin down.

" The team tracked this process in real time using fluorescent neural imaging and found that psychedelics increase slow-frequency brainwave oscillations — specifically 5-Hz waves — in visual areas. These waves then stimulate the retrosplenial cortex, a brain region deeply involved in accessing stored memories. The result is what Professor Jancke describes as "a bit like partial dreaming" — the brain shifts from processing external reality to replaying and reorganizing internal experience.

Why This Matters for People Considering Psychedelic Treatment This finding is not just academic. It offers a biological explanation for why psychedelic experiences — including ibogaine sessions — can feel so deeply personal and transformative. Many people who undergo ibogaine treatment report vivid, autobiographical visions: replaying childhood memories, confronting past traumas, or experiencing life events from new perspectives. This study suggests that the brain is literally reorganizing its relationship to stored memory during these experiences.

For people struggling with addiction, PTSD, or treatment-resistant depression, this reorganization may be exactly what allows them to break free from entrenched patterns. The traumatic memories and compulsive thought loops that drive these conditions are, in a sense, being re-accessed and re-filed by a brain that has temporarily turned down the noise of the outside world. The MindScape Perspective At MindScape Retreat, we see this phenomenon in practice every week. Patients frequently describe their ibogaine experience as a life review — not a hallucination in the recreational sense, but a deeply structured encounter with their own history.

Research like this validates what our clinical team has observed: ibogaine does not simply interrupt withdrawal or reset receptor sensitivity. It appears to create a window in which the brain can fundamentally reprocess the experiences that underlie addiction and trauma. This is also why medical supervision matters so much. The depth of the ibogaine experience — now better understood as a neurological shift from external processing to deep memory access — requires a safe, controlled setting with cardiac monitoring and experienced clinical staff.

The brain is doing extraordinary work during these sessions, and the environment needs to support that. Research suggests that understanding these mechanisms will eventually lead to more refined treatment protocols and better patient outcomes. We are watching this space closely.

Source: White, C

et al. "Psychedelic 5-HT2A agonist increases spontaneous and evoked 5-Hz oscillations in visual and retrosplenial cortex.

" Communications Biology , 2026

ScienceDaily Considering ibogaine treatment? [Learn about MindScape Retreat's medically supervised program →](https://mindscaperetreat.